(0.12%) 5 303.27 points
(0.34%) 40 004 points
(-0.07%) 16 686 points
(0.97%) $80.00
(5.73%) $2.64
(1.44%) $2 419.80
(6.36%) $31.78
(2.18%) $1 094.70
(-0.02%) $0.920
(-0.18%) $10.68
(-0.27%) $0.787
(0.19%) $91.05
-6.74% CHF 3.18
Live Chart Being Loaded With Signals
AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding...
Stats | |
---|---|
Dagens volum | 550 055 |
Gjennomsnittsvolum | 776 085 |
Markedsverdi | 315.45M |
EPS | CHF0 ( 2024-05-17 ) |
Neste inntjeningsdato | ( CHF-0.150 ) 2024-06-21 |
Last Dividend | CHF0 ( N/A ) |
Next Dividend | CHF0 ( N/A ) |
P/E | -4.54 |
ATR14 | CHF0.0130 (0.41%) |
Volum Korrelasjon
AC Immune SA Korrelasjon
10 Mest positive korrelasjoner | |
---|---|
ADPT | 0.896 |
ASTS | 0.889 |
WKHS | 0.888 |
NEOG | 0.881 |
SCPH | 0.881 |
SOPA | 0.881 |
AEHR | 0.88 |
OM | 0.88 |
ALTM | 0.877 |
BCDA | 0.876 |
10 Mest negative korrelasjoner | |
---|---|
KRUS | -0.862 |
MASI | -0.835 |
SFBC | -0.828 |
ADTH | -0.827 |
KINS | -0.822 |
INBKZ | -0.819 |
EDAP | -0.818 |
EDUC | -0.815 |
LPCN | -0.812 |
TAYD | -0.81 |
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
AC Immune SA Korrelasjon - Valuta/Råvare
AC Immune SA Økonomi
Annual | 2023 |
Omsetning: | CHF14.80M |
Bruttogevinst: | CHF-39.81M (-268.93 %) |
EPS: | CHF-0.640 |
FY | 2023 |
Omsetning: | CHF14.80M |
Bruttogevinst: | CHF-39.81M (-268.93 %) |
EPS: | CHF-0.640 |
FY | 2022 |
Omsetning: | CHF3.94M |
Bruttogevinst: | CHF-56.40M (-1 433.32 %) |
EPS: | CHF-0.850 |
FY | 2021 |
Omsetning: | CHF0.00 |
Bruttogevinst: | CHF0.00 (0.00 %) |
EPS: | CHF-0.970 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
AC Immune SA
AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectively interact with misfolded proteins that are common in a range of neurodegenerative diseases. The company is developing Crenezumab, a humanized, conformation-specific monoclonal antibody, which is in Phase II clinical prevention trial for the treatment of Alzheimer's disease (AD). It is also developing ACI-24, an anti-Abeta vaccine candidate that is in Phase II clinical study for AD, as well as completed Phase Ib clinical study for Down syndrome; ACI-35, an anti-Tau vaccine candidate that has completed Phase Ib clinical study; and Tau- positron emission tomography (PET) imaging tracer, which is in Phase II clinical study. In addition, the company is researching and developing small molecule Tau aggregation inhibitors for AD and NeuroOrphan indications. Further, it has discovery and preclinical stage molecules targeting range of neurodegenerative diseases, which include diagnostics targeting TDP-43, alpha-synuclein, and NLRP3. AC Immune SA has license agreements and collaborations with Genentech, Inc.; Biogen International GmbH; Janssen Pharmaceuticals, Inc.; Life Molecular Imaging SA; Eli Lilly and Company; and WuXi Biologics. The company was incorporated in 2003 and is headquartered in Lausanne, Switzerland.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.